Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$1.14 - $1.81 $17,058 - $27,084
14,964 New
14,964 $20,000
Q1 2023

Apr 13, 2023

SELL
$2.84 - $3.92 $5,697 - $7,863
-2,006 Reduced 7.54%
24,593 $95,000
Q4 2022

Jan 23, 2023

SELL
$2.48 - $5.93 $24,626 - $58,884
-9,930 Reduced 27.18%
26,599 $0
Q3 2022

Oct 26, 2022

BUY
$4.08 - $5.82 $46,565 - $66,423
11,413 Added 45.44%
36,529 $199,000
Q2 2022

Jul 25, 2022

SELL
$4.15 - $8.37 $97,948 - $197,548
-23,602 Reduced 48.45%
25,116 $113,000
Q1 2022

May 02, 2022

BUY
$5.91 - $14.38 $60,128 - $146,302
10,174 Added 26.4%
48,718 $359,000
Q4 2021

Jan 28, 2022

BUY
$5.21 - $8.61 $200,814 - $331,863
38,544 New
38,544 $247,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $51.1M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.